Subcutaneous injections Healthcare professionals administer subcutaneous injections into the fatty tissue just under the skin and above the muscle tissue. They will use a smaller needle to give ...
Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed noninferiority ...
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...
Keytruda Qlex, a subcutaneous formulation, is FDA-approved for solid tumors in patients 12 and older, offering an alternative to intravenous administration. Study MK-3475A-D77 showed comparable ...
Healthcare professionals give intradermal injections just below the surface of the skin, creating a small bump called a bleb or wheal. The intradermal injection route has the longest absorption time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback